SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-12-002146
Filing Date
2012-03-06
Accepted
2012-03-06 08:01:02
Documents
12
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2207753z10-k.htm 10-K 1032286
2 EX-23.1 a2207753zex-23_1.htm EX-23.1 5894
3 EX-31.1 a2207753zex-31_1.htm EX-31.1 7721
4 EX-31.2 a2207753zex-31_2.htm EX-31.2 7753
5 EX-32.1 a2207753zex-32_1.htm EX-32.1 5279
12 G599256.JPG g599256.jpg GRAPHIC 39501
  Complete submission text file 0001047469-12-002146.txt   3511810

Data Files

Seq Description Document Type Size
6 EX-101.INS rigl-20111231.xml EX-101.INS 441636
7 EX-101.SCH rigl-20111231.xsd EX-101.SCH 16330
8 EX-101.CAL rigl-20111231_cal.xml EX-101.CAL 40656
9 EX-101.LAB rigl-20111231_lab.xml EX-101.LAB 243026
10 EX-101.PRE rigl-20111231_pre.xml EX-101.PRE 118914
11 EX-101.DEF rigl-20111231_def.xml EX-101.DEF 72943
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29889 | Film No.: 12668795
SIC: 2834 Pharmaceutical Preparations